Skip to main content

Advertisement

Log in

IgA nephropathy in adult-onset Still’s disease after tocilizumab treatment: a case report

  • Nephrology - Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Code availability

Not applicable.

References

  1. Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430

    CAS  PubMed  Google Scholar 

  2. Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402–2414. https://doi.org/10.1056/NEJMra1206793

    Article  CAS  PubMed  Google Scholar 

  3. Li X, Ma J, Zhao Y, Wang HY, Li XM (2015) Development of crescentic immunoglobulin a nephritis and multiple autoantibodies in a patient during adalimumab treatment for rheumatoid arthritis. Chin Med J (Engl) 128:2555–2556. https://doi.org/10.4103/0366-6999.164992

    Article  Google Scholar 

  4. Stokes MB, Foster K, Markowitz GS, Ebrahimi F, Hines W, Kaufman D, Moore B, Wolde D, D’Agati VD (2005) Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 20:1400–1406. https://doi.org/10.1093/ndt/gfh832

    Article  CAS  PubMed  Google Scholar 

  5. Wendling D, Humbert P, Hory B, Blanc D, Dupond JL, Guidet M (1989) The kidney in Still’s disease in adults. Rev Rhum Mal Osteoartic 56:325–327

    CAS  PubMed  Google Scholar 

  6. Toussirot E, Aubin F (2016) Paradoxical reactions under TNF-alpha blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview. RMD Open 2:e000239. https://doi.org/10.1136/rmdopen-2015-000239

    Article  PubMed  PubMed Central  Google Scholar 

  7. Su H, Lei CT, Zhang C (2017) Interleukin-6 signaling pathway and its role in kidney disease: an update. Front Immunol 8:405. https://doi.org/10.3389/fimmu.2017.00405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Taniguchi Y, Yorioka N, Kumagai J, Katsutani M, Kuratsune M, Amimoto D, Yamakido M (1999) Interleukin-6 localization and the prognosis of IgA nephropathy. Nephron 81:94–98. https://doi.org/10.1159/000045254

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ji-Hyoun Kang.

Ethics declarations

Conflict of interest

The author has declared no conflicts of interest.

Informed consent

The patient has given written consent to publish his personal and medical information for the publication of the case report.

Consent to participate

Informed consent was obtained from the patient, and the patient consent declaration form has been provided.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, JH. IgA nephropathy in adult-onset Still’s disease after tocilizumab treatment: a case report. Int Urol Nephrol 54, 1167–1168 (2022). https://doi.org/10.1007/s11255-021-02956-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-021-02956-x

Navigation